Virtue® SAB Mimics Elution Profile of Proven Drug-Eluting Stents
Preclinical testing was conducted in 130 pigs and over 750 distinct artery treatment sites. Data demonstrated pharmacokinetics that mimic drug release profile of known drug-eluting stents and therapeutic levels of drug in arterial tissue with low systemic concentrations EuroIntervention Journal in 2016.1
Virtue SAB Enables Therapeutic Arterial Tissue Concentrations with Low Systemic Concentrations
1Juan F. Granada, et al. In vivo delivery and long-term tissue retention of nano- encapsulated sirolimus using a novel porous balloon angioplasty system. EuroIntervention 2016;12:740-747.